Exonavis leverages the unique intercellular communication function of Exosomes (out-of-cell small particles) to develop an innovative multidrug delivery platform, enabling a first-of-its-kind targeted delivery of proteins and RNA and opening a new path of personalized, targeted, and high efficacy therapy for various diseases, ranging from genetic disorders to cancer.

Exonavis is developing a unique production process from cultivation to ready-to-use-dose, using state of the art bioreactors and isolation machinery.

Exonavis has successfully achieved a robust exosome production ability, as well as the characterization protocol of exosomes derived from Mesenchymal stem cells